BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1101946)

  • 21. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
    Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
    Russell JA; Harrison DJ; McNeilly AS
    J Endocrinol; 1981 Apr; 89(1):91-8. PubMed ID: 6894307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 27. The suppression of puerperal lactation with bromocryptine.
    Willmott MP; Colhoun EM; Bolton AE
    Acta Obstet Gynecol Scand; 1977; 56(2):145-9. PubMed ID: 324230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lactation.
    Llewellyn-Jones D
    Drugs; 1975; 10(2):121-9. PubMed ID: 1175477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of postpartum breast engorgement: double-blind comparison of chlorotrianisene 72 mg. and placebo.
    Phillips WP
    J Ark Med Soc; 1975 Sep; 72(4):163-7. PubMed ID: 127773
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premenstrual tension and functional infertility. Aetiology and treatment.
    Benedek-Jaszmann LJ; Hearn-Sturtevant MD
    Lancet; 1976 May; 1(7969):1095-8. PubMed ID: 57506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum prolactin levels in women with excessive milk production. Normalization by transitory prolactin inhibition.
    Peters F; Geisthövel F; Breckwoldt M
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):463-6. PubMed ID: 3898690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind trial of chlorotrianisene in the suppression of lactation.
    Binns DT
    Practitioner; 1967 Nov; 199(193):685-8. PubMed ID: 4863299
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
    Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA
    Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    Morin P; Engelmann P; Coustenoble G; Lebrun ; Gueris D
    Nouv Presse Med; 1975 Nov; 4(39):2811-2. PubMed ID: 1105425
    [No Abstract]   [Full Text] [Related]  

  • 39. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.